Host: |
Sheep/Sheep |
Applications: |
ELISA |
Reactivity: |
Human |
Note: |
FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS. |
Short Description: |
This CD109 antibody pair contains complimentary capture and detection antibodies, which work together under the principals of the Sandwich ELISA. |
Conjugation: |
Unconjugated/Biotin |
Formulation: |
Capture Buffer: PBS with 0.04% Proclin 300; 50% glycerol; pH 7.5.Detection Buffer: PBS with 0.04% Proclin 300; 1% protective protein; 50% glycerol; pH 7.5. |
Purification: |
Capture Purification: Antigen Affinity.Detection Purification: Antigen Affinity. |
Concentration: |
0.5 mg/mL |
Storage Instruction: |
Store at-20°C for long term, and avoid freeze-thaw cycles. |
Determination Method: |
Colormetric |
Gene Symbol: |
CD109 |
Gene ID: |
135228 |
Uniprot ID: |
CD109_HUMAN |
Immunogen: |
Capture immunogen: Recombinant Human CD109 protien.Detection Immunogen: Recombinant Human CD109 protien. |
Sample Type: |
Serum, plasma and other biological fluids |
Post Translational Modifications | N-glycosylated. 2 forms of 150 (p150) and 120 kDa (p120) exist due to proteolytic degradation from a 180 kDa form. |
Function | Modulates negatively TGFB1 signaling in keratinocytes. |
Protein Name | Cd109 Antigen150 Kda Tgf-Beta-1-Binding ProteinC3 And Pzp-Like Alpha-2-Macroglobulin Domain-Containing Protein 7Platelet-Specific Gov AntigenP180R150Cd Antigen Cd109 |
Database Links | Reactome: R-HSA-114608Reactome: R-HSA-163125 |
Cellular Localisation | Cell MembraneLipid-AnchorGpi-Anchor |
Alternative Antibody Pair Names | Cd109 Antigen antibody pair150 Kda Tgf-Beta-1-Binding Protein antibody pairC3 And Pzp-Like Alpha-2-Macroglobulin Domain-Containing Protein 7 antibody pairPlatelet-Specific Gov Antigen antibody pairP180 antibody pairR150 antibody pairCd Antigen Cd109 antibody pairCD109 antibody pairCPAMD7 antibody pair |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance